Stereospecific high–performance liquid chromatographic assay for the enantiomers of phenylpropanolamine in human plasma

C. S. Stockley, L. M.H. Wing, J. O. Miners

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Abstract

A stereospecific high-performance liquid chromatographic assay for the enantiomers of phenylpropanolamine (PPA) in human plasma has been developed. The method is based on reaction of extracted PPA with the chiral derivatizing agent 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate to form diastereomeric thiourea derivatives. These thiourea derivatives are stable for at least 24 h, readily separable by reversed-phase chromatography, and amenable to ultraviolet detection at 254 nm. Standard curves for each of the PPA enantiomers are linear over the concentration range 10–250 μg/L. Over the approximate range of the standard curve, precision (intra- and interday) ranged from 2.2–7.0% while accuracy ranged from 99.2–107.3%. The method has been shown to be free from interference from endogenous plasma constituents and from a range of drugs containing a primary or secondary amine function. Individual PPA enantiomer plasma concentration-time profiles measured for a subject administered racemic PPA are included to demonstrate the utility of the assay.

Original languageEnglish
Pages (from-to)332-338
Number of pages7
JournalTHERAPEUTIC DRUG MONITORING
Volume13
Issue number4
DOIs
Publication statusPublished - Jul 1991
Externally publishedYes

Keywords

  • High-performance liquid chromatography
  • Phenylpropanolamine
  • Plasma concentrations
  • Stereospecific analysis

Fingerprint Dive into the research topics of 'Stereospecific high–performance liquid chromatographic assay for the enantiomers of phenylpropanolamine in human plasma'. Together they form a unique fingerprint.

Cite this